Latest news
Genomic Testing for Cancer Patients Still Rare Despite Medicare Coverage - Inside Precision MedicineInside Precision Medicine · Wed, 05 Aug 2026 16:32:00 GMTNext-Generation Sequencing Uptake Remains Low Among Medicare Beneficiaries, Study Finds - The ASCO PostThe ASCO Post · Tue, 04 Aug 2026 15:00:39 GMTMedicare Genomic Testing Uptake Triples but NGS Gaps Persist in Cancer Care - Oncology Nursing NewsOncology Nursing News · Tue, 04 Aug 2026 13:05:48 GMTInflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT